Shionogi & Co., Ltd.
SGIOF
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.34T
Close$
Share Statistics
| Market cap | $2.34 Trillion |
|---|---|
| Enterprise Value | $2.72 Trillion |
| Dividend Yield | $0.48 (2.77%) |
| Earnings per Share | $242.87 |
| Beta | 0.03 |
| Outstanding Shares | 850,975,000 |
Return
| Return on Equity | 14.99% |
|---|---|
| Return on Assets | 10.01% |
| Return on Invested Capital | 11.85% |
Valuation & Multiples
| P/E Ratio | 8.86 |
|---|---|
| PEG | 6.1 |
| Price to Sales | 0.03 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 4.81 |
| Enterprise Value to EBIT | 12.55 |
| Enterprise Value to Net Income | 10 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$0.29
Average shareholder expectationRevenue Estimate
$1.00 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.24
Average shareholder expectationRevenue Estimate
$1.12 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shionogi & Co., Ltd.
6,223 employees
CEO: Isao Teshirogi Shionogi & Co., Ltd., an Osaka, Japan-based pharmaceutical company established in 1878, focuses on the discovery, development, production, and commercialization of medicines, diagnostic tools, and medical devices primarily within Japan. ...